This site is intended for healthcare professionals
Drug news

Pembrolizumab (formerly lambrolizumab) being MK 3475 success in Phase 1b trial for Head & Neck Cancer

Read time: 1 mins
Last updated:6th Jun 2014
Published:6th Jun 2014
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest